TMCnet News
Vertex Awards 40 Scholarships Totaling $200,000 to People Living with Cystic Fibrosis and Their Immediate Family MembersVertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the first recipients of the company's All in for CF Scholarship program. Each of the 40 scholarship recipients will be awarded $5,000 for the 2017-2018 academic year. Vertex (News - Alert) established the All in for CF Scholarship program to help people with cystic fibrosis (CF) and their immediate family members pursue two-year, four-year or graduate degrees. These scholarships complement other Vertex initiatives that help people with CF live active lives, improve awareness of CF, and support independent basic science and clinical research. "Vertex is focused on discovering and developing transformative medicines for people with CF, but our commitment to the community extends far beyond this," said Jeffrey Leiden, M.D., Ph.D., Chairman, President and Chief Executive Officer of Vertex. "Our new scholarship program reflects the fact that CF impacts entire families by helping people with CF, their caregivers, siblings and children pursue their academic goals." Scholarship recipients were chosen by an independent committee of CF community members based on a submitted essay and an applicant's demonstrated level of community involvement, financial need, and academic achievement. Vertex thanks the members of the CF community who volunteered to serve on the selection committee, for their time and commitment. "I believe I was given a second chance to inspire, love and help others," said Carly Wheeler, who is living with CF and received a double lung transplant last year. "The All in for CF Scholarship will help me work toward doing that. I plan to study genetics and, one day, join the fight againstCF and other diseases to give people the opportunity of a full life." This fall, Wheeler will enroll as a sophomore at Southern Illinois University at Edwardsville to study biology. More information about the All in for CF Scholarship, including biographies for some of this year's recipients, can be found here.
About Cystic Fibrosis
About Vertex Founded in 1989 in Cambridge, Mass., Vertex today has research and development sites and commercial offices in the United States, Europe, Canada and Australia. For seven years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences. For additional information and the latest updates from the company, please visit www.vrtx.com.
Vertex Is All In for CF (VRTX-GEN)
View source version on businesswire.com: http://www.businesswire.com/news/home/20170519005078/en/ |